All In Biotech

Drug Trial Radar · NCT00311779

A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis

Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study

Last checked: Nov 20, 2026Latest source record: Jul 12, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Mar 2006

Primary completion

Not stated

Study completion Jul 2006

Sponsor

Lead sponsor
ParaPRO LLCIndustry
Sponsor type
Industry
First posted
Apr 6, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Factorial
Masking
Single
Primary purpose
Treatment
Who can join
All sexes, from 2 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).

Conditions

  • Pediculosis Capitis (Head Lice)

Interventions

  • Spinosad Creme RinseDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy variable: The presence/absence of live lice and/or nits at Day 7 and Day 14.
  2. Safety Analyses: The assessment of safety will be based on frequency of adverse events and on the scalp evaluations for irritation.

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Hill Top Resesarch

    Scottsdale, Arizona

  • Hill Top Research

    West Palm Beach, Florida

  • Hill Top Research

    Miamiville, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.